“…The potential of kaempferol to increase energy expenditure should not be dismissed because this flavonoid may contribute to an increase in skeletal myocyte oxygen consumption of up to 30%, can affect regulation of metabolically important genes and activate thyroid hormones [25]. ↓ glucose uptake Catechin 3T3-L1 adipocytes 50 μM 30 min translocation of GLUT4 through activation of PI3K [62] ↓, decrease; ↑, increase; STAT-1, signal transducers and activators of transcription; NF-kB, nuclear factor kappa B; iNOS, inducible nitric oxide synthase; COX-2, ciclooxigenase-2; AP-1, activator protein 1; PPAR-γ, peroxisome proliferator-activated receptors-γ; TNF-, tumour necrosis factor-; IL, interleukin; AMPk, AMP-activated protein kinase; MAPK, mitogen-activated protein kinase; ERK, extracellular signal-regulated kinases; JNK, c-Jun N-terminal protein kinases; C/EBPα, CCAAT/enhancer binding protein; SIRT1, sirtuin-1; FFA, free fatty acid. ↓, decrease; ↑, increase; COX-2, ciclo-oxygenase2; iNOS, inducible nitric oxide synthase; TNF-α , tumor necrosis factor-α; INF-γ, interferon-gamma; IL, interleukin; TEE, total energy expenditure; PPAR-γ, peroxisome proliferator-activated receptors-γ; 8-isso-PGF2α, prostaglandin2;AMPK, AMP-activated protein kinase; UCP1, mitochondrial uncoupling proteins; IGF-1, insulin-like growth factor 1; PGC-1 α , peroxisome proliferator-activated receptor-gamma coactivator 1 alpha; RMR, resting metabolic rate; Sirt1, sirtuin-1; GLP-1, glucagon-like peptide-1; SIRT1, sirtuin-1; HOMA, homeostasis model assessment; VEGF, vascular endothelial growth factor; VEGFR-2, vascular endothelial growth factor receptor 2 ↓, decrease; ↑, increase; BMI, body mass index, LDL-c, low-density-lipoprotein cholesterol It is noteworthy that most studies on these compounds have been performed In vitro with the aim to clarify mechanisms of action; they have been focused on elucidating implications for inflammation.…”